查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386584

移植HLA型检测市场报告：2030 年趋势、预测与竞争分析

HLA Typing for Transplant Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

移植HLA型检测的趋势与预测

到 2030 年，全球可移植HLA型检测市场预计将达到 13 亿美元，2024 年至 2030 年年复合成长率为 8.2%。该市场的主要驱动力是器官移植手术数量的增加、移植医学的持续进步以及自体免疫疾病盛行率的增加。全球HLA型检测移植市场的未来充满希望，独立参考实验室、医院和移植中心、实验室和学术机构市场都有机会。

移植HLA型检测市场洞察

Lucintel 预测，由于快速处理样本的高通量、检测多种 HLA 等位基因的能力以及卓越的准确性，分子分型将继续成为较大的细分市场。

由于拥有强大的医疗基础设施、先进移植诊断技术的广泛接受度以及该地区主要参与者的存在，北美将继续成为最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球移植市场HLA型检测：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球移植市场的HLA型检测趋势（2018-2023年）与预测（2024-2030年）
  • 按产品类型HLA型检测移植分型
    • 试剂/消耗品
    • 装置
    • 软体服务
  • 透过科技进行全球移植的HLA型检测
    • 分子检测技术
    • 非分子检测技术
  • 按应用进行移植的全球HLA型检测
    • 诊断
    • 研究
    • 其他的
  • 按最终用途产业HLA型检测
    • 独立参考实验室
    • 医院/移植中心
    • 研究/学术机构
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 按地区分類的用于移植的全球HLA型检测
  • 北美用于移植的HLA型检测
  • 欧洲移植的HLA型检测
  • 亚太地区用于移植的HLA型检测
  • 用于其他地区移植的HLA型检测

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球HLA型检测分型移植市场成长机会
    • 全球HLA型检测技术带来的移植市场成长机会
    • 全球HLA型检测移植市场成长机会（按应用）
    • 全球移植HLA型检测市场成长机会（依最终用途产业划分）
    • 按地区分類的全球移植HLA型检测市场成长机会
  • 全球移植市场HLA型检测的新趋势
  • 战略分析
    • 新产品开发
    • 全球移植HLA型检测市场的产能扩张
    • 全球移植HLA型检测市场的合併与收购企业
    • 认证和许可

第7章主要企业概况

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Qiagen
  • Omixon
  • GenDx
  • Illumina
  • TBG Diagnostics
  • Dickinson
  • Takara Bio
  • F. Hoffman-La Roche
简介目录

HLA Typing for Transplant Trends and Forecast

The future of the global HLA typing for transplant market looks promising with opportunities in the independent reference laboratory, hospital and transplant centre, and research laboratory & academic institute markets. The global HLA typing for transplant market is expected to reach an estimated $1.3 billion by 2030 with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rising number of organ transplant procedures, continuous advancements in transplant medicine, and increasing prevalence of autoimmune diseases.

A more than 150-page report is developed to help in your business decisions.

HLA Typing for Transplant by Segment

The study includes a forecast for the global HLA typing for transplant by product type, technology, application, end use industry, and region.

HLA Typing for Transplant Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Reagents and Consumables
  • Instruments
  • Software and Services

HLA Typing for Transplant Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Molecular Assay Technologies
  • Non- Molecular Assay Technologies

HLA Typing for Transplant Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic
  • Research
  • Others

HLA Typing for Transplant Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Independent Reference Laboratories
  • Hospitals and Transplant Centres
  • Research Laboratories and Academic Institutes
  • Others

HLA Typing for Transplant Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of HLA Typing for Transplant Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HLA typing for transplant companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HLA typing for transplant companies profiled in this report include-

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Qiagen
  • Omixon
  • GenDx
  • Illumina
  • TBG Diagnostics
  • Dickinson
  • Takara Bio
  • F. Hoffman-La Roche

HLA Typing for Transplant Market Insights

Lucintel forecasts that molecular will remain the larger segment due to its high throughput for the quick processing of samples, ability to detect wide variety of HLA alleles, and excellent accuracy.

North America will remain the largest region due to existence of robust healthcare infrastructure, widespread acceptance of advanced transplant diagnostic technologies, and presence of key players in the region.

Features of the Global HLA Typing for Transplant Market

Market Size Estimates: HLA typing for transplant market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HLA typing for transplant market size by various segments, such as by product type, technology, application, end use industry, and region in terms of ($B).

Regional Analysis: HLA typing for transplant market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end use industries, and regions for the HLA typing for transplant market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HLA typing for transplant market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the HLA typing for transplant market size?

Answer: The global HLA typing for transplant market is expected to reach an estimated $1.3 billion by 2030.

Q.2 What is the growth forecast for HLA typing for transplant market?

Answer: The global HLA typing for transplant market is expected to grow with a CAGR of 8.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the HLA typing for transplant market?

Answer: The major drivers for this market are rising number of organ transplant procedures, continuous advancements in transplant medicine, and increasing prevalence of autoimmune diseases.

Q4. What are the major segments for HLA typing for transplant market?

Answer: The future of the HLA typing for transplant market looks promising with opportunities in the independent reference laboratory, hospital and transplant centre, and research laboratory & academic institute markets.

Q5. Who are the key HLA typing for transplant market companies?

Answer: Some of the key HLA typing for transplant companies are as follows:

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Qiagen
  • Omixon
  • GenDx
  • Illumina
  • TBG Diagnostics
  • Dickinson
  • Takara Bio
  • F. Hoffman-La Roche

Q6. Which HLA typing for transplant market segment will be the largest in future?

Answer: Lucintel forecasts that molecular will remain the larger segment due to its high throughput for the quick processing of samples, ability to detect wide variety of HLA alleles, and excellent accuracy.

Q7. In HLA typing for transplant market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to existence of robust healthcare infrastructure, widespread acceptance of advanced transplant diagnostic technologies, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the HLA typing for transplant market by product type (reagents and consumables, instruments, and software and services), technology (molecular assay technologies and non- molecular assay technologies), application (diagnostic, research, and others), end use industry (independent reference laboratories, hospitals and transplant centres, research laboratories and academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global HLA Typing for Transplant Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global HLA Typing for Transplant Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global HLA Typing for Transplant Market by Product Type
    • 3.3.1: Reagents and Consumables
    • 3.3.2: Instruments
    • 3.3.3: Software and Services
  • 3.4: Global HLA Typing for Transplant Market by Technology
    • 3.4.1: Molecular Assay Technologies
    • 3.4.2: Non- Molecular Assay Technologies
  • 3.5: Global HLA Typing for Transplant Market by Application
    • 3.5.1: Diagnostic
    • 3.5.2: Research
    • 3.5.3: Others
  • 3.6: Global HLA Typing for Transplant Market by End Use Industry
    • 3.6.1: Independent Reference Laboratories
    • 3.6.2: Hospitals and Transplant Centres
    • 3.6.3: Research Laboratories and Academic Institutes
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global HLA Typing for Transplant Market by Region
  • 4.2: North American HLA Typing for Transplant Market
    • 4.2.1: North American HLA Typing for Transplant Market by Technology: Molecular Assay Technologies and Non- Molecular Assay Technologies
    • 4.2.2: North American HLA Typing for Transplant Market by End Use Industry: Independent Reference Laboratories, Hospitals and Transplant Centres, Research Laboratories and Academic Institutes, and Others
  • 4.3: European HLA Typing for Transplant Market
    • 4.3.1: European HLA Typing for Transplant Market by Technology: Molecular Assay Technologies and Non- Molecular Assay Technologies
    • 4.3.2: European HLA Typing for Transplant Market by End Use Industry: Independent Reference Laboratories, Hospitals and Transplant Centres, Research Laboratories and Academic Institutes, and Others
  • 4.4: APAC HLA Typing for Transplant Market
    • 4.4.1: APAC HLA Typing for Transplant Market by Technology: Molecular Assay Technologies and Non- Molecular Assay Technologies
    • 4.4.2: APAC HLA Typing for Transplant Market by End Use Industry: Independent Reference Laboratories, Hospitals and Transplant Centres, Research Laboratories and Academic Institutes, and Others
  • 4.5: ROW HLA Typing for Transplant Market
    • 4.5.1: ROW HLA Typing for Transplant Market by Technology: Molecular Assay Technologies and Non- Molecular Assay Technologies
    • 4.5.2: ROW HLA Typing for Transplant Market by End Use Industry: Independent Reference Laboratories, Hospitals and Transplant Centres, Research Laboratories and Academic Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global HLA Typing for Transplant Market by Product Type
    • 6.1.2: Growth Opportunities for the Global HLA Typing for Transplant Market by Technology
    • 6.1.3: Growth Opportunities for the Global HLA Typing for Transplant Market by Application
    • 6.1.4: Growth Opportunities for the Global HLA Typing for Transplant Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global HLA Typing for Transplant Market by Region
  • 6.2: Emerging Trends in the Global HLA Typing for Transplant Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global HLA Typing for Transplant Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HLA Typing for Transplant Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Bio-Rad Laboratories
  • 7.3: Qiagen
  • 7.4: Omixon
  • 7.5: GenDx
  • 7.6: Illumina
  • 7.7: TBG Diagnostics
  • 7.8: Dickinson
  • 7.9: Takara Bio
  • 7.10: F. Hoffman-La Roche